Guy's and St Thomas' Hospital, London, UK
Gerry Dolan qualified from Glasgow University Medical School and held training posts in internal medicine and haematology in Glasgow, Edinburgh and Sheffield before being appointed as a consultant haematologist. He is Head of Department and Clinical Lead of the Haemostasis and Thrombosis Service at Guy's and St Thomas' Hospital in London, UK.
Dr Dolan has been on the Executive Committee of the United Kingdom Haemophilia Centre Doctors Organisation (UKHCDO) since 1997 and is the current Chairman. He is Past President of the British Society of Haemostasis and Thrombosis (BSHT). He is also the Clinical Chair of NHS England's Clinical Reference Group for Haemophilia, and Chair of the European Haemophilia Therapy Standardisation Board (EHTSB).
Dr Dolan's interests include clinical outcomes in haemophilia, the management of older adults with haemophilia, and molecular aspects of bleeding disorders.
Skåne University Hospital, Lund/Malmö, Sweden
Jan Astermark is Professor at Lund University, Director of the Malmö Centre for Thrombosis and Haemostasis, and Head of Haematology at the Skåne University Hospital in Lund/Malmö, Sweden. He is a specialist in haematology, coagulation disorders and internal medicine.
Prof Astermark is a reviewer for several haematology journals, and has published a number of original articles, review articles and book chapters in the field of haemophilia and coagulation disorders. He also serves as the Principal Investigator for large international multicentre studies with a special focus on inhibitor development in haemophilia.
University Hospitals Paris Sud, Bicêtre Hospital, Le Kremlin-Bicêtre, Paris, France
Roseline d’Oiron is a physician and Associate Director of the Reference Centre for Haemophilia and Other Congenital Rare Bleeding Disorders at the University Hospitals Paris Sud, Bicêtre Hospital in Le Kremlin-Bicêtre, France.
Dr d’Oiron received her MD from the Pierre and Marie Curie University in Paris, and completed her speciality training with Masters in Haematology, Immunology, Immunopathology and Transfusion Medicine.
Dr d’Oiron’s research interests are principally in the area of haemophilia in both children and adults, especially in molecular mechanisms of haemophilia A, inhibitors, immune tolerance, mild/moderate haemophilia and carrier issues. She is also exploring other topics including women with bleeding disorders and Glanzmann’s thrombasthenia.
Dr d’Oiron has served as a member of the Steering Committee of the national FranceCoag Network on bleeding disorders and continues to serve as an advisor to the working group on inhibitors in this registry. She has served a two-year term as an elected member of the Executive Committee of the European Association for Haemophilia and Allied Disorders (EAHAD). With the National Federation of Patients, she has also developed an outreach program dedicated to women from families with haemophilia.
Catholic University of Louvain, Brussels, Belgium
Cedric Hermans currently heads the Hemostasis and Thrombosis Unit and the Hemophilia Center of the Saint-Luc University Hospital in Brussels, Belgium. He was appointed Associate Professor at the Medical School of the Catholic University of Louvain in 2003, Full Professor in 2012 and Vice-Dean in 2015.
Dr Hermans has (co)-authored more than 200 original articles in international journals and is a member of several scientific societies and international advisory boards. He is past-president of EAHAD and was recently appointed as member of the Board of Directors of the World Federation of Haemophilia.
Dr Hermans’ main research interests lie in the area of haemostasis and thrombosis, especially clinical studies on the treatment of haemophilia, new anticoagulants, and the management of thrombosis.
Oslo University Hospital, Oslo, Norway
Pål André Holme is the Professor of Haematology at Oslo University Hospital in Norway. He graduated from the Medical School at the University of Oslo in 1993 and was a research fellow at the Institute for Internal Medicine, University of Oslo, where he received his PhD in 1996 after studies on platelet activation and platelet-derived microparticle formation. He is a specialist in internal medicine and haematology.
Professor Holme has been responsible for the treatment of adult patients with haemophilia and bleeding related disorders in Norway since 2006. He participates in several clinical research groups and has been an active investigator in studies on bleeding related disorders and platelets. He has authored many papers published in peer-reviewed journals and textbook chapters on these subjects.
Vivantes Hospital, Berlin, Germany
Robert Klamroth is Director of the Haemophilia Treatment Centre and Head of the Department for Internal Medicine/Angiology and Coagulation Disorders at the Vivantes Hospital in Berlin, Germany. He graduated from the Free University of Berlin and received his specialisation in internal medicine in 2001 following by vascular medicine and haemostaseology. He is adjunctive professor for haemostaseology at the university of Bonn since 2017.
One of Dr Klamroth's primary interests is the utility of recombinant replacement factors for the treatment of life-threatening bleeding disorders. His clinical research includes the development of and participation in clinical trials (phase I-IV), as well as publishing in the field of haemophilia and coagulation disorders.
In addition, Dr Klamroth is a speaker for the Haemophilia Commission of the German Society of Thrombosis and Haemostasis and an Executive Committee member of the European Association for Haemophilia and Allied Disorders (EAHAD).
Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, Milan, Italy
Maria Elisa Mancuso is a haematologist working as a clinical assistant at the Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre in Milan, Italy. She received a postgraduate degree in clinical and experimental haematology and her PhD in Clinical Methodology.
Dr Mancuso is involved in clinical research and has published several original articles in peer-reviewed journals such as Blood, Journal of Thrombosis and Haemostasis, Haematologica, Thrombosis and Haemostasis, British Journal of Haematology and Haemophilia.
Dr Mancuso is a member of several scientific societies including the International Society on Thrombosis and Haemostasis (ISTH), the World Federation of Hemophilia (WFH), the American Society of Hematology (ASH), and the European Association for Haemophilia and Allied Disorders (EAHAD). She is a member of the ISTH Scientific and Standardization Subcommittee on factor VIII, factor IX and rare bleeding disorders. She has been a co-investigator in several clinical trials, and takes care of both children and adults with haemophilia with a specific scientific interest in inhibitors and chronic hepatitis C.
University Medical Centre Utrecht, Utrecht, The Netherlands
Roger Schutgens is a consultant haematologist at the University Medical Centre (UMC) Utrecht in the Netherlands. His main responsibilities include care, research and education in the area of haematology, with a special focus on benign haematologic disorders and clotting diseases. He is Head of Department at the Van Creveld Clinic, Centre for Benign Haematology, Thrombosis and Haemostasis at the UMC Utrecht.
Prof Schutgens completed his medical degree at the University of Leuven in Belgium and completed his PhD at Utrecht University, in the Netherlands. He is Chair of the Blood Transfusion Committee and of the Anticoagulation Committee at the UMC Utrecht.
Prof Schutgens’ areas of focus include patients predisposed to bleeds, congenital abnormalities of platelets and hypercoagulable conditions. His research in haemophilia focuses on cardiovascular disease in haemophilia and haemophilic arthropathy.
Glasgow Royal Infirmary, Glasgow, UK
Campbell Tait is a consultant haematologist and Director of the Adult Haemophilia and Thrombosis Centre at the Royal Infirmary in Glasgow, UK. He is an Honorary Professor of Haemostasis & Thrombosis at the University of Glasgow, where he also studied and attained degrees in immunology and medicine. Professor Tait is Chair of the NHS Greater Glasgow and Clyde Thrombosis Committee. He has been an active member of National Guideline committees (SIGN and BCSH) for anticoagulation, bleeding disorders and thrombosis. His research interests include bleeding disorders, thrombophilia, anticoagulation, and coagulation activation markers as predictors of venous and arterial thrombosis.
If you are a healthcare professional and would like more information on ADVANCE topics please click "Healthcare Professional".
If you are a patient or member of the public and would like more information on ADVANCE topics please click "Patient or Member of the Public".